Standards; Pharmaceutical/API Drug Impurities/Metabolites;
应用:
5,5'-(Piperazine-1,4-diyl)bis(pyridin-2-amine) is an impurity of Palbociclib (P139900), an experimental drug for the treatment of breast cancer being developed by Pfizer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6.